Article Details

Sangamo Therapeutics Inc. (NASDAQ:SGMO)'s 12-Month Price Target Currently Stands At $30.00

Retrieved on: 2021-07-31 19:52:30

Tags for this article:

Click the tags to see associated articles and topics

Sangamo Therapeutics Inc. (NASDAQ:SGMO)'s 12-Month Price Target Currently Stands At $30.00. View article details on HISWAI: https://marketingsentinel.com/2021/07/31/sangamo-therapeutics-inc-nasdaqsgmos-12-month-price-target-currently-stands-at-30-00/

Excerpt

And as of Mar 30, 2021, it was holding 7.18% of the company's outstanding shares. The second largest institutional holder is Blackrock Inc., which was ...

Article found on: marketingsentinel.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up